Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| BeiGene Ltd ADR | 8 | 1 | 1 | 0 | €146.00 | €255.89 | 75.267% |
| Formycon AG | 3 | 1 | 0 | 0 | €42.45 | €100.00 | 135.571% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 1 | €40.00 | €50.00 | 25.000% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €33.20 | €50.00 | 50.602% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €3.22 | €34.41 | 968.714% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.83 | €30.00 | 960.071% |
| SI-BONE Inc | 15 | 1 | 1 | 1 | €13.10 | €23.59 | 80.075% |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 0 | €1.55 | €18.30 | 1081.912% |
| scPharmaceuticals | 3 | 1 | 0 | 1 | €4.06 | €16.43 | 304.690% |
| Novavax Inc. | 3 | 2 | 0 | 0 | €4.00 | €12.00 | 200.225% |
| Ocular Therapeutix Inc. | 8 | 5 | 0 | 1 | €4.47 | €11.70 | 161.543% |
| Palisade Bio Inc. | 2 | 1 | 1 | 1 | €0.34 | €11.28 | 3205.129% |
| Pacific Biosciences of California Inc. | 10 | 5 | 3 | 2 | €1.50 | €10.20 | 581.586% |
| Trevena Inc. | 1 | 13 | 1 | 3 | €0.35 | €8.37 | 2276.818% |
| Orasure Tech | 3 | 1 | 0 | 1 | €4.88 | €8.36 | 71.277% |
| Agenus Inc. | 2 | 3 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.26 | €7.00 | 209.735% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 2 | €0.75 | €6.53 | 766.755% |
| Chimerix Inc. | 4 | 1 | 0 | 0 | €0.84 | €5.51 | 557.282% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 1 | 1 | €1.32 | €5.10 | 284.872% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 16 | 0 | 1 | €2.82 | €5.03 | 78.387% |
| Avinger Inc. | 2 | 7 | 0 | 0 | €0.34 | €4.64 | 1272.633% |
| Karyopharm Therapeutics Inc. | 7 | 2 | 1 | 0 | €1.03 | €3.65 | 255.694% |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.94 | €3.00 | 54.999% |